PSMA is a 100 kDa type II transmembrane glycosylated protein and as the name implies, is overexpressed in nearly all prostate cancers cells, its expression is 100–1000 times higher in tumor tissues compared to normal tissues (Wright et al., 1995). The gene discussed is FOLH1; the disease is prostate carcinoma.